Understand the source comparison
Sermorelin Energy Complete Guide 2026: Protocol Comparison
Typical Dose 300–500 mcg sermorelin once daily 300 mcg sermorelin + 100 mcg GHRP-2 once daily 300 mcg sermorelin + 200 mcg ipamorelin once daily Stacking amplifies GH pulse amplitude but increases cost and injection complexity GH Pulse Amplitude 2–3× baseline
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Typical Dose
- 300–500 mcg sermorelin once daily
- 300 mcg sermorelin + 100 mcg GHRP-2 once daily
- 300 mcg sermorelin + 200 mcg ipamorelin once daily
- Stacking amplifies GH pulse amplitude but increases cost and injection complexity
- GH Pulse Amplitude
- 2–3× baseline
- 4–6× baseline
- 3–5× baseline
- GHRP-2 produces strongest pulse but also elevates cortisol and prolactin
- Energy Onset Timeline
- 8–12 weeks
- 4–8 weeks
- 6–10 weeks
- Faster onset with stacks due to greater GH exposure, but individual variation is high
- Side Effect Profile
- Minimal (injection site reactions, transient flushing)
- Moderate (increased appetite, water retention, cortisol elevation)
- Low-moderate (mild appetite increase, rare flushing)
- Ipamorelin is most selective for GH without prolactin/cortisol cross-reactivity
- Cost (Monthly)
- $80–$150
- $150–$250
- $180–$280
- Stacks nearly double cost; justified only if monotherapy produces suboptimal IGF-1 response
- Bottom Line
- Best first-line approach for most users
- Reserve for non-responders to monotherapy or advanced protocols
- Middle-ground option offering synergy without GHRP-2's cortisol spike
- Start with sermorelin monotherapy and escalate only if biomarkers show inadequate response
- The CJC1295 Ipamorelin 5MG 5MG combination represents an alternative stacking strategy using CJC-1295 (a longer-acting GHRH analogue) instead of sermorelin, which extends GH pulse duration but also increases the risk of GH receptor desensitization with chronic use.